Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.
Kajiwara Y, Tazawa H, Yamada M, Kanaya N, Fushimi T, Kikuchi S, Kuroda S, Ohara T, Noma K, Yoshida R, Umeda Y, Urata Y, Kagawa S, Fujiwara T. Kajiwara Y, et al. Among authors: urata y. Cancer Immunol Immunother. 2023 May;72(5):1285-1300. doi: 10.1007/s00262-022-03334-x. Epub 2022 Nov 27. Cancer Immunol Immunother. 2023. PMID: 36436021 Free PMC article.
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
Mochizuki Y, Tazawa H, Demiya K, Kure M, Kondo H, Komatsubara T, Sugiu K, Hasei J, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Mochizuki Y, et al. Among authors: urata y. Cancer Immunol Immunother. 2021 May;70(5):1405-1417. doi: 10.1007/s00262-020-02774-7. Epub 2020 Nov 5. Cancer Immunol Immunother. 2021. PMID: 33151368 Free PMC article.
Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer.
Araki H, Tazawa H, Kanaya N, Kajiwara Y, Yamada M, Hashimoto M, Kikuchi S, Kuroda S, Yoshida R, Umeda Y, Urata Y, Kagawa S, Fujiwara T. Araki H, et al. Among authors: urata y. Mol Ther Oncolytics. 2022 Sep 13;27:3-13. doi: 10.1016/j.omto.2022.09.003. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36212775 Free PMC article.
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y, Tazawa H, Hashimoto Y, Kojima T, Kuroda S, Yano S, Yoshida R, Uno F, Mizuguchi H, Ohtsuru A, Urata Y, Kagawa S, Fujiwara T. Yamasaki Y, et al. Among authors: urata y. Eur J Cancer. 2012 Sep;48(14):2282-91. doi: 10.1016/j.ejca.2011.12.020. Epub 2012 Jan 13. Eur J Cancer. 2012. PMID: 22244827
Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer.
Takehara K, Tazawa H, Okada N, Hashimoto Y, Kikuchi S, Kuroda S, Kishimoto H, Shirakawa Y, Narii N, Mizuguchi H, Urata Y, Kagawa S, Fujiwara T. Takehara K, et al. Among authors: urata y. Mol Cancer Ther. 2016 Jan;15(1):199-208. doi: 10.1158/1535-7163.MCT-15-0344. Epub 2015 Dec 1. Mol Cancer Ther. 2016. PMID: 26625896
456 results